|5Sep 20, 8:42 PM ET

Symetryx Corp 5

5 · NeuBase Therapeutics, Inc. · Filed Sep 20, 2023

Insider Transaction Report

Form 5
Period: 2022-12-31
Symetryx Corp
10% Owner
Transactions
  • Other

    Common Stock, par value $0.0001

    2023-09-180192,481 total
Footnotes (1)
  • [F1](1) Symetryx Corporation reported the sales of all its Common Stock of Issuer on Form 4 filed 9/18/2023. Barry and Aleta Shiff are beneficial owners of shares listed.

Documents

1 file
  • 5
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT